A feasibility study of short hydration regimen for lung cancer patients receiving cisplatin-based chemotherapy

A feasibility study of short hydration regimen for lung cancer patients receiving cisplatin-based chemotherapy - A feasibility study of short hydration regimen for lung cancer patients receiving cisplatin-based chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011687

Enrollment

Registered

2013-10-01

Start date

2013-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

short hydration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)patients with pathologically proven lung cancer 2)patients recieving cisplatin dose of 60mg/m2 or above 3)patients without treatment history of chemotherapy 4)20 years of age or older, 75 years of age or younger 5)appropriate organ function 6)adequate renal function serum creatinine level under 1.5mg/dl creatinine clearance over 60ml/min 7)oxigen saturation on room air over 90% 8)Performance status (ECOG) 0-1 9)written informed consent

Exclusion criteria

Exclusion criteria: 1)active infection 2)pregnant or lactating woman and possibility of the pregnancy in the six months after completion of the study 3)a histroy of a severe drug allergy 4)severe comobidity 5)judged to be inappropriate by the attending doctor

Design outcomes

Primary

Measure	Time frame
proportion of the patients without grade 2 to 4 creatinine elevation based on NCI-CTCAE ver4.0	—

Countries

Japan

Contacts

Public ContactTetsunari Hase

Nagoya University graduate scool of medicine department of respiratory medicine

thase@med.nagoya-u.ac.jp052-744-2167

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026